Vehicle sheet

PROCEDURE4 trials

Sponsors

Anterogen Co., Ltd.

Conditions

Diabetic Foot Ulcer

Phase 3

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.

CompletedNCT03370874

Anterogen Co., Ltd.Diabetic Foot Ulcer

Start: 2018-06-27End: 2020-02-20Updated: 2023-08-25

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

CompletedNCT04569409

Anterogen Co., Ltd.Diabetic Foot Ulcer

Start: 2020-07-14End: 2024-12-05Updated: 2025-09-22

Unknown Phase

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial

CompletedNCT04590703

Anterogen Co., Ltd.Diabetic Foot Ulcer

Start: 2020-06-24End: 2023-06-02Updated: 2023-08-25

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

RecruitingNCT06141811

Anterogen Co., Ltd.Diabetic Foot Ulcer

Start: 2023-04-25End: 2026-03-31Target: 104Updated: 2024-12-13